Telix Pharmaceuticals (TLX) Goodwill & Intangibles (2023 - 2026)

Telix Pharmaceuticals (TLX) has reported Goodwill & Intangibles for 3 consecutive years, with $791.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Goodwill & Intangibles rose 190.96% year-over-year to $791.8 million; the TTM figure through Dec 2025 stood at $791.8 million (up 190.96% YoY), while the FY2025 annual figure was $791.8 million, up 190.96% from the prior year.
• Goodwill & Intangibles climbed to $791.8 million in Q4 2025 per TLX's latest filing, from $272.1 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $791.8 million in Q4 2025 and bottomed at $71.4 million in Q4 2023.
• Historically, Goodwill & Intangibles has averaged $378.4 million across 3 years, with a median of $272.1 million in 2024.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles surged 281.2% — and 2025, when it jumped 190.96%.
• Telix Pharmaceuticals' Goodwill & Intangibles stood at $71.4 million in 2023, then soared by 281.2% to $272.1 million in 2024, then soared by 190.96% to $791.8 million in 2025.
• Business Quant data shows TLX's Goodwill & Intangibles at $791.8 million in Q4 2025, $272.1 million in Q4 2024, and $71.4 million in Q4 2023.